Navigation Links
Michigan Life Science and Innovation Center Opens in Former Pfizer Facility
Date:9/24/2009

PLYMOUTH TOWNSHIP, Mich., Sept. 24 /PRNewswire/ -- The Michigan Economic Development Corp. (MEDC), Ann Arbor SPARK, Greater Wayne Economic Development Corporation and a private foundation have collaborated to create the Michigan Life Science and Innovation Center (MLSIC). MLSIC will connect well-funded, experienced entrepreneurs with business accelerator organizations and start-up life science companies.

"By offering state-of-the-art labs and start-up support in one location, MLSIC will be a catalyst for the growth of biotech and life sciences companies in southeast Michigan," said Michael A. Finney, president of Ann Arbor SPARK. "Access to wet lab space will help emerging life sciences companies conduct critical research, and access established biotech entrepreneurs - MLSIC's anchor tenants - is a resource that can help growing companies overcome obstacles, get good business advice and further propel their growth."

MLSIC is a 57,518 sq. ft. facility that offers office space, in addition to the state-of-the-art laboratory facilities. MEDC, Ann Arbor SPARK, Greater Wayne Economic Development Corporation and a private foundation contributed a combined $4.5 million to purchase the facility from Pfizer.

Current research and innovation taking place at MLSIC includes focused drug development, clinical research organization (CRO), biological processes, and life science services. At its grand opening, MLSIC is home to several companies:

  • Algal Scientific Corporation, a biotech company working to develop a system to convert proprietary algal strain into fuel.
  • Chef House Catering, a catering and events planning company and the MLSIC cafe operator.
  • Distributed Compliance Solutions, LLC, a compliance solutions hosting firm for the small to medium size biotechnology, life science companies and government agencies delivering scalable, economical, and reliable turnkey solutions within state-of-the-art hosting facilities.
  • Esperion Therapeutics, Inc., a life sciences company that discovers and develops therapies to prevent, treat, and reverse cardiovascular and metabolic diseases.
  • Lifetime Nutrition, LLC, a clinic focused on nutrition and lifestyle consulting.
  • Lycera Corporation, a biotech firm working to develop small molecule drugs for the treatment of psoriasis, rheumatoid arthritis, lupus and cancer.
  • Milad Pharmaceuticals Consulting, a company that provides pharmaceutical consulting for pharmaceutical kinetics/pharmaceutical development.
  • Next Generation Therapeutics, Inc., a biotechnology company that focuses on novel Nano and Microplatforms for drug delivery and imaging of cancer and in-licensing promising pharmaceutical and medical device technologies.
  • Velesco Pharmaceutical Services, a CRO that provides laboratory services and clinical supplies to smaller pharmaceutical companies.

MLSIC's ongoing operational costs will be funded through a combination of public, private and foundation support.

Business acceleration services offered at MLSIC will include peer-to-peer mentoring that will connect experienced entrepreneurs with start-up ventures. Additional business acceleration services offered will include access to wet lab and research space, funding support and other critical services.

ABOUT ANN ARBOR SPARK

Ann Arbor SPARK, a non-profit organization, is the driving force in establishing the Ann Arbor region as a destination for business expansion, retention, and location by identifying and meeting the needs of business at every stage, from startups to large organizations. Ann Arbor SPARK represents all communities in the Washtenaw County. Ann Arbor SPARK collaborates with business, academic, government, and community investor partners including the University of Michigan, Eastern Michigan University, Washtenaw Community College, Michigan Works!/ETCS, Washtenaw County, the City of Ann Arbor, the Bank of Ann Arbor and the Michigan Economic Development Corporation. For more information, please call (734) 761-9317 or visit www.AnnArborUSA.org.


'/>"/>
SOURCE Ann Arbor SPARK
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. University of Michigan Study Shows SEQUENOMs MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
2. Michigan Catholic Conference Welcomes Announcement of Non-Embryo Destructive Stem Cell Research Advancement
3. American College of Cardiology and Center of Excellence for Simulation Research of Western Michigan University (CESR) Partner for in situ Simulation to Improve Team Communication and Door-to-Balloon (D2B) Time
4. Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm
5. First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan
6. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
7. Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup
8. Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season
9. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
10. Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
11. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Tenn. and DALLAS , April 19, 2017 ... announced that the first patients in Nashville ... device in the Lower Esophageal Sphincter Stimulation for GERD ... implantable device designed to provide long-term reflux control by ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... April 19, 2017  New research provides evidence that an ... according to a study released today that will be presented ... in Boston , April 22 to ... treatment of Parkinson,s disease, the oral drug levodopa has long ... longevity. But as the disease progresses, the effects of the ...
Breaking Medicine Technology:
(Date:4/24/2017)... RICHEY, Fla. (PRWEB) , ... April 24, 2017 ... ... and Prevention (CDC), rising prescription opioid overdose deaths now claim the lives of ... slashed its civil case filings against drug manufacturers, distributors, pharmacies and prescribers by ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively ... it is not known to have significant interactions with antiretroviral therapy (ART). ... cholesterol levels and dampen inflammation in the bloodstream. , While lowering cholesterol and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Donna Parker, L. Ac. reads all sorts of ... of them to be very practical. She wanted to write a guide/workbook that would ... their health. It prompted her in writing “ A Clear Path to a Vibrant ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, ... Trin, and Omega Station” is the creation of published author, Chris Jackson. Chris ... where he works in the Dallas Independent School District teaching English. He is heavily ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), ... ANCD BRAIN device as the product advances towards regulatory and clinical phases. , ...
Breaking Medicine News(10 mins):